Φορτώνει......
Identification of an anti-diabetic, orally available, small molecule that regulates TXNIP expression and glucagon action
Diabetes is characterized by hyperglycemia, loss of functional islet beta-cell mass, deficiency of glucose-lowering insulin and persistent alpha-cell secretion of gluconeogenic glucagon. Still, no therapies that target these underlying processes are available. We therefore performed high-throughput...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Metab |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7501995/ https://ncbi.nlm.nih.gov/pubmed/32726606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2020.07.002 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|